City of Hope Comprehensive Cancer Center
Who we are
City of Hope's mission is to deliver the cures of tomorrow to the people who need them today.
Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives.
City of Hope’s system of provider and research entities now serves approximately 134,000 patients each year, with over 11,000 team members, 600 physicians and more than 1,000 scientists and researchers across a network of locations in California, Arizona, Illinois and Georgia.
The growing national system includes its Los Angeles campus, a network ofclinical care locations across Southern California, a new cancer center in Orange County, California, and treatment facilities in Atlanta, Chicago and Phoenix. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHope. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram and LinkedIn.